Longevity Treatments for a 91-Year-Old? A Bold Bet in Silicon Valley’s Immortality Race - The Information
Source:The Information
In Silicon Valley, some quests for the fountain of youth have most definitely won the backing of tech’s leading names. Sam Altman, OpenAI’s CEO, personally invested $180 million to launch Retro Biosciences, which is working on ways to rejuvenate aging cells. …
Related Articles
A scientist questioned new microplastics findings. Then other researchers fired back. - The Washington Post
A prominent scientist criticized microplastics research methods. Others are defending the work.
Dad Went to Bed with a Cough and Died of a Cardiac Arrest. 6 Years Later, the Same Happened to His Son (Exclusive) - AOL.com
Jason Selvey died six years before his son, Daniel, due to the rare genetic illness Alagille …
COVID pandemic enters seventh year with no end in sight - Boing Boing
It’s strange to think that the COVID-19 pandemic, which sent the world into lockdown seven …
New U.S. guidance says to consume less alcohol. What does that mean? - Milwaukee Journal Sentinel
The new dietary guidelines are the first since 1980 to not define what drinking in moderation looks …